Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F042 - Young Physician Pearls and Pitfalls: A Survival Guide for the First 10 Years

Friday, February 16; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe and navigate the daily regulatory hurdles encountered in practice; delineate the organizational structure of the AAD and AADA; and recognize opportunities for young physician involvement.
  • Recognize the interactions between state medical societies and the AAD; and Identify opportunities for involvement in state medical societies.
  • Determine how to incorporate mid-level providers in your practice; and identify challenges that you may encounter in private practices or in an academic setting.

Description

The first ten years of practice bring unique challenges in an ever-changing healthcare system. For young physicians, it's not only important to keep up with medical advances, but also to be able to efficiently run their practice. Many also feel the need and desire to give back and continue to advance our great specialty. This session will give young physicians the tools needed to continue to be successful, including, knowledge of regulatory hurdles in a changing practice landscape, involvement in state medical societies, working with mid-level providers and begin an academic career.

Disclosures

  • Bennett, Daniel D., MD: no financial relationships exist with commercial interests.
  • Bhatia, Neal D., MD: Aclaris Therapeutics, Inc. – I(Grants/Research Funding); Actavis – I(Grants/Research Funding); Allergan, Inc – C(H); Almirall – C(H); Aqua – C(H); Asana Biosciences, LLC – I(Grants/Research Funding); Atacama Therapeutics – I(Grants/Research Funding); Bayer Pharmaceuticals – C(H); Biofrontera AG – C(H); BioPharmX – I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Cipher Pharmaceuticals – C(H); Crown Laboratories, Inc. – I(Grants/Research Funding); Cutanea Life Sciences – I(Grants/Research Funding); Dermira – I(Grants/Research Funding); DUSA Pharmaceuticals, Inc. – I(Grants/Research Funding); Ferndale Laboratories, Inc. – C(H); Foamix – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H); Glenmark Generics Inc. – I(Grants/Research Funding); IntraDerm Pharmaceuticals – C(H); ISDIN – C(H); La Roche-Posay Laboratorie Pharmaceutique – C(H); LEO Pharma, US – I(Grants/Research Funding); Mayne Pharma Group – C(H); MC2 Therapeutics – I(Grants/Research Funding); Menlo Therapeutics – I(Grants/Research Funding); Mylan Technologies Inc. – C(H); Novartis Pharmaceuticals Corp. – C(H); Ortho Dermatologics – C(H); Par Pharmaceutical – I(Grants/Research Funding); Perrigo Company – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – C(H); Promius Pharma, LLC – A(H); Realm Therapeutics – I(Grants/Research Funding); Sanofi/Regeneron – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Skinfix, Inc. – A(H); Sol-Gel Technologies – I(Grants/Research Funding); Soligenix, Inc – I(Grants/Research Funding); Strata Skin Sciences – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – C(H); Valeant Pharmaceuticals International – C(H); Viamet Pharmaceuticals, Inc – I(Grants/Research Funding); Vidac Pharma – I(Grants/Research Funding); Vyome Biosciences – I(Grants/Research Funding);
  • Brauer, Jeremy A., MD: Cynosure – SP(H); Cynosure, Inc – A(H); Merz Aesthetics – C(H);
  • Huang, William, MD: Dermatology Foundation – B(NC), I(Grants/Research Funding); DermTreat – C(NC), I(NC); Genentech, Inc. – SP(H); Gilead Sciences – I(NC); Roche Laboratories – I(NC);
  • Pendharkar, Ninad C., MD, MBA: no financial relationships exist with commercial interests.
  • Resneck, Jack S. Jr., MD: no financial relationships exist with commercial interests.
  • Van Beek, Marta Jane, MD, MPH: no financial relationships exist with commercial interests.
Event Details
  • Date
    Friday, February 16
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 5B
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Jeremy A. Brauer, MD, FAAD
Speakers
  • Daniel D. Bennett, MD, FAAD
  • Jack S. Resneck Jr., MD, FAAD
  • Marta Jane Van Beek, MD, MPH, FAAD
  • Neal D. Bhatia, MD, FAAD - Handout
  • Ninad C. Pendharkar, MD, MBA, FAAD
  • William Huang, MD, FAAD